Clinical Trials Browser

Clear-cell metastatic renal cell carcinoma × sitravatinib × Genitourinary × Clear all

NCT04904302 2026-03-16

Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer

Phase 2 Terminated

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell